CAH
Cardinal Health (CAH)
NYSE
$227.12+$4.38 (+1.97%)
Price as of Jun 23, 2026 2:30 PM EDT
  • $52.2B
    Market Cap
  • 37.36%
    1-Year Change
  • Medical Distribution
    Industry

Key Performance

More
  • Earnings Score: 50
  • Momentum Score: 79
  • True Yield: 22
  • Financial Health Score: 55
TradeSmith Loading

Latest Research & News

[Latest] Surgical Masks Market Size Will Attain USD 6.76 Billion by 2034 Registering a Promising CAGR of 5.5% - Exclusive Report by ZMR | Global Surgical Masks Market Size, Share, Trends Analysis Report

The global surgical masks market is projected to grow from USD 3.95 billion in 2024 to USD 6.76 billion by 2034 at a CAGR of 5.5%. Growth is driven by rising healthcare applications, infection control awareness, and surgical interventions, though environmental concerns about disposal and competition from alternative respirators pose challenges. Europe is expected to lead the market, while basic surgical masks will dominate the product segment.

06/08/2026, 7:00 AM • GlobeNewswire

Pregnancy Detection Kits Market Analysis Report 2026 - Competitive Landscape, Opportunities, and Forecasts, 2021-2025 & 2025-2031

The global pregnancy detection kits market is projected to grow from USD 1.91 billion in 2025 to USD 2.69 billion by 2031, with a CAGR of 5.87%. Growth is driven by technological advancements enabling earlier detection, rising infertility rates, and increasing adoption of digital integration and e-commerce distribution. However, the market faces challenges from accuracy concerns and user error risks that erode consumer trust.

05/08/2026, 4:47 AM • GlobeNewswire

Cardinal Health Board of Directors Approves Quarterly Dividend

Cardinal Health's Board of Directors approved an increase to its quarterly dividend to $0.5158 per share, payable on July 15, 2026 to shareholders of record as of July 1, 2026. The dividend will be paid out of the company's capital surplus.

05/05/2026, 4:40 PM • Benzinga

Stock Market Today: Dow Jones Roars As Industrials Rescue Wall Street From Meta-Led Tech Slide

The Dow Jones surged 1.5% driven by industrial and healthcare stocks, while mega-cap tech faced pressure from concerns over AI capital spending. Meta and Microsoft declined on capex worries, but Alphabet gained on enterprise AI wins. Industrials like Caterpillar, Quanta Services, and Carrier rallied on data-center infrastructure demand. The S&P 500 gained 0.5% while the Nasdaq 100 remained flat.

04/30/2026, 1:09 PM • Benzinga

Why Is Cardinal Health Stock Sinking Thursday?

Cardinal Health reported mixed Q3 2026 earnings with an EPS beat of $3.17 vs. $2.79 consensus, but revenue missed at $60.94B vs. $61.70B expected. Despite raising full-year guidance and reporting strong operational performance, the stock fell 8.23% to $186.12, likely due to the revenue miss and flat performance in the medical products segment.

04/30/2026, 11:20 AM • Benzinga

Radiopharmaceuticals Market Size to Exceed USD 15.21 Billion By 2035 Rising Cancer Cases Boost the Market Demand

The global radiopharmaceuticals market is projected to grow from USD 8.28 billion in 2026 to USD 15.21 billion by 2035, driven by rising cancer and cardiovascular disease incidence. North America dominates with 43.95% market share, while Asia-Pacific is expected to register the fastest growth. Therapeutic radiopharmaceuticals and Technetium-99m lead their respective segments, with hospitals and clinics as the primary end users.

04/24/2026, 9:57 AM • GlobeNewswire

Robotic Pharmacy Prescription Market Research and Global Forecast Report 2025-2032

The global robotic pharmacy prescription market is experiencing significant growth, expanding from USD 214.16 million in 2025 to USD 237.65 million in 2026, with a projected CAGR of 9.18% through 2032, reaching USD 396.21 million. The market is driven by automation adoption for medication safety and efficiency, workforce transformation toward clinical roles, and bundled solution procurement strategies across hospitals, clinics, and long-term care facilities.

04/09/2026, 4:57 AM • GlobeNewswire

Biopharmaceutical Third Party Logistics (Distribution Management, Packaging & Labeling, Transportation, Warehousing) Market Research and Global Forecast Report 2026-2032

The biopharmaceutical third-party logistics market is expected to grow from $140.03 billion in 2025 to $384.23 billion by 2032, with a CAGR of 15.51%. Growth is driven by rising product complexity, regulatory scrutiny, cold chain integrity demands, and technological advancements in digital tracking and specialized handling for biologics and gene therapies.

04/09/2026, 4:49 AM • GlobeNewswire

3 Dividend Stocks With High Returns on Invested Capital

The article examines three high-ROIC dividend-paying stocks: MasterCard, which reported strong Q4 2025 earnings with 17.3% revenue growth and 19% annual EPS growth; Starbucks, showing accelerating comparable store sales growth to 4% with expansion opportunities in China; and Cardinal Health, a major drug distributor posting 18.6% revenue growth and 39 consecutive years of dividend increases.

03/31/2026, 4:45 PM • Investing

Global Medical Device Cleaning Market Poised for Strong Growth as Infection Control Mandates and Reprocessing Technologies Accelerate Adoption: Verified Market Research®

The global medical device cleaning market is projected to grow from USD 2.08 billion in 2024 to USD 3.74 billion by 2032, driven by escalating infection prevention requirements, expanding reusable device utilization, and technological advancements in automated reprocessing systems. However, high capital costs, complex regulatory obligations, and workforce training variability pose challenges to uniform adoption across regions.

02/27/2026, 10:55 AM • GlobeNewswire

Cardinal Health Board of Directors Approves Quarterly Dividend

Cardinal Health's Board of Directors approved a quarterly dividend of $0.5107 per share, payable on April 15, 2026 to shareholders of record as of April 1, 2026. The dividend will be paid from the company's capital surplus.

02/12/2026, 4:45 PM • Benzinga

Cardinal Health Smashes 52-Week High After Strong Quarter

Cardinal Health (CAH) surged 9.11% to a new 52-week high after reporting strong Q2 results with adjusted EPS of $2.63 (beating consensus of $2.35) and sales of $65.63 billion (+19% YoY). The company raised its fiscal 2026 guidance for adjusted EPS to $10.15-$10.35 (+23% to +26% growth) and raised profit growth guidance across multiple segments.

02/05/2026, 10:18 AM • Benzinga

How the Largest IPO of 2025 Could Be Healthy for Your Portfolio

Medline Industries, the largest IPO of 2025, is positioned as an attractive investment opportunity. The Chicago-based medical supply company has demonstrated strong historical growth with 18% average annual sales growth since 1966 and 50 consecutive years of net sales growth. With a $375 billion total addressable market and solid free cash flow projections, analysts expect continued momentum, though the stock trades at a lofty P/E multiple of 28.

02/05/2026, 1:15 AM • The Motley Fool

United States Personal Protective Equipment (Gowns, Masks, Face Shields and Others) Market Outlook to 2033

A comprehensive market report on the U.S. Personal Protective Equipment market covering gowns, masks, face shields, gloves and other segments through 2033. The report provides revenue, volume, and pricing data across market segments with company share information for 2024, identifying key opportunities for market entry, expansion, and investment strategies.

02/04/2026, 11:00 AM • GlobeNewswire

AOP Health’s Rapiblyk™ Now Accessible via Leading US Healthcare Improvement Companies

AOP Health US announced expanded distribution of Rapiblykâ„¢ (landiolol), an FDA-approved ultra-short-acting beta-blocker for treating rapid heart rates in critical care settings. The drug is now available through four major pharmaceutical wholesalers: Cardinal, Cencora Specialty Distribution, McKesson Corporation, and Morris & Dickson, enhancing accessibility for hospitals and health systems nationwide.

01/12/2026, 9:00 AM • GlobeNewswire

Peers

Statistics

More
Day Range
$222.28
$228.45
$222.74
1-Year Range
$146.04
$229.88
$222.74
Latest Close$222.74
Change
+$0.97 (+0.44%)
Volume2,886,149
Market Cap$52.2B
Shares Outstanding234.2M
P/E (TTM)34.05
Diluted EPS (TTM)$6.54
Enterprise Value$57.1B

Information as of 06/22/2026

Company Profile

$52.2B
Market Cap
$1.6B
Net Income
Sector: Healthcare
Industry: Medical Distribution
7000 Cardinal Place, Dublin, OH, United States, 43017
614 757 5000

Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.

Key Executives

  • Jason Hollar
  • Aaron E. Alt
  • Deborah L. Weitzman
  • Jessica L. Mayer
  • Stephen Mason

Current Ownership Distribution

  • Institutions3.9B (68.05%)
  • Mutual Funds1.8B (31.85%)
  • Insiders5.7M (0.10%)
  • Other0 (0.00%)